Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
HIRAYAMA HOLDINGS, 4% Increase in Ordinary Profit, Update Record High for Seventh Consecutive Term, Dividend Raised by 1 Yen
7781 HIRAYAMA HOLDINGS Co.,Ltd. 【J-GAAP】
Earnings ReportHIRAYAMA HOLDINGS Co.,Ltd. <7781> [TSE Std] announced its financial results after the market closed on August 14th (16:00). The consolidated ordinary profit for the fiscal year ended June 2025 increased by 11.5% from the previous period to 1.30 billion yen. For the fiscal year ending June 2026, the consolidated ordinary profit is expected to grow by 3.8% to 1.34 billion yen, marking the seventh consecutive term of record-high profits. This will be the sixteenth consecutive term of revenue and the tenth consecutive term of profit growth.
At the same time, the company has decided to increase the dividend this fiscal year to 51 yen, an increase of 1 yen from the previous fiscal year.
In the most recent three-month period, from April to June (4Q), the consolidated ordinary profit decreased to 0.24 billion yen, an 8.5% decrease compared to the same period last year. The operating profit margin remained almost flat, changing from 2.9% in the same period last year to 2.9%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jun, 2023 | 31,674 | 893 | 948 | 549 | 75.0 | 25 | Aug 14, 2023 | J-GAAP |
| Jun, 2024 | 35,292 | 1,119 | 1,166 | 757 | 102.3 | 42 | Aug 14, 2024 | J-GAAP |
| Jun, 2025 | 36,220 | 1,270 | 1,300 | 858 | 112.4 | 50 | Aug 14, 2025 | J-GAAP |
| YoY | +2.6% | +13.5% | +11.5% | +13.3% | +9.8% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jun, 2025 Guidance | 38,000 | 1,347 | 1,336 | 850 | 111.0 | 50 | Aug 14, 2024 | J-GAAP |
| Jun, 2025 Results | 36,220 | 1,270 | 1,300 | 858 | 112.4 | 50 | Aug 14, 2025 | J-GAAP |
| Revision Rate | -4.7% | -5.7% | -2.7% | +0.9% | +1.2% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Dec, 2024 | 18,051 | 747 | 776 | 491 | 64.5 | 16 | Feb 14, 2025 | J-GAAP |
| Jul - Dec, 2025 Guidance | ー | ー | ー | ー | - | 16 | Aug 14, 2025 | J-GAAP |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jun, 2024 | 35,292 | 1,119 | 1,166 | 757 | 102.3 | 42 | Aug 14, 2024 | J-GAAP |
| Jun, 2025 | 36,220 | 1,270 | 1,300 | 858 | 112.4 | 50 | Aug 14, 2025 | J-GAAP |
| Jun, 2026 Guidance | 37,770 | 1,341 | 1,349 | 883 | 115.2 | 51 | Aug 14, 2025 | J-GAAP |
| YoY | +4.3% | +5.6% | +3.8% | +2.9% | +2.5% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Jun, 2024 | 9,028 | 264 | 270 | 174 | 23.5 | 2.9 | Aug 14, 2024 | J-GAAP |
| Jul - Sep, 2024 | 8,844 | 301 | 326 | 211 | 27.9 | 3.4 | Nov 14, 2024 | J-GAAP |
| Oct - Dec, 2024 | 9,207 | 446 | 450 | 280 | 36.8 | 4.8 | Feb 14, 2025 | J-GAAP |
| Jan - Mar, 2025 | 8,829 | 255 | 277 | 185 | 24.3 | 2.9 | May 15, 2025 | J-GAAP |
| Apr - Jun, 2025 | 9,340 | 268 | 247 | 182 | 23.8 | 2.9 | Aug 14, 2025 | J-GAAP |
| YoY | +3.5% | +1.5% | -8.5% | +4.6% | +1.3% |
Related Articles
Cytori Cell Research Institute, Apr-Jun (1Q) Ordinary Profit Loss Narrows
PIXELA, Oct-Jun (Cumulative 3Q) Net Income Loss Narrows, Apr-Jun Net Income Loss Narrows
Allied Architects, The Current Fiscal Year's Net Income to Widen
HABA LABORATORIES, Apr-Jun (1Q) Ordinary Profit Turns to Profit
NIPPON TECHNO LAB, Apr-Jun (1Q) Ordinary Profit Loss Narrows
PA, First Half Ordinary Profit Increases by 2.7 times
Sincere, First Half Ordinary Profit Increases by 45%, Apr-Jun Ordinary Profit Increases by 17%
UNICAFE, Ordinary Profit Forecast for the Fiscal Year Revised Upward to an Unexpected 49% Increase
UNIVERSAL ENGEISHA, 15% Increase in Ordinary Profit, Update Record High for Eighth Consecutive Term
Beaglee, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 20%, Dividend Revised down by 6 Yen